---
category: news
title: "AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)"
excerpt: "AI Therapeutics, Inc., an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the acquisition of EntreChem, S.L.â€™s investigational drug candidate EC-8042 (redesignated AIT-102),"
publishedDateTime: 2022-04-25T14:41:00Z
originalUrl: "https://www.tmcnet.com/usubmit/2022/04/25/9588739.htm"
webUrl: "https://www.tmcnet.com/usubmit/2022/04/25/9588739.htm"
type: article
quality: 7
heat: 7
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI

secured: "xl/qY+QObkWh6xMZpPSncVSPkzZzQoilrMsGj04tDDdvOrKU5BVGwa1FcbtvpIQV9fN4p59KTduzRttOKL+gXDZvsyjshbwCDYakm8bWWkAW0b4yys+ySHWSWVbWVDOym4hOnhRH+5NGhc3p06dS22i5L/nLmHL097DZSKQV0IOW+A+InKOHJM41KCHlUIAXnyOI//DQyJOJ8zPmRhruMqwuHlOHBoQyGG8KQa6rYEWe3nnNGZuOjNWKYg9bG9AZkdZW7Ku/tM3nSTBhZQNP3RIQPgDRJW/ZPnqEQw6vSgqa3bLJIn6L7FHDOL/Jfl9haqxfxV9J9dsHi2rRIsMh+uTkSMHv2X3nrwPHKHnfBdg=;8NcstlSGESHVGBYOTyG5sA=="
---

